| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $60.2M | +0.9% | -19.0% |
| Cost of Revenue | $17.2M | -4.5% | -29.9% |
| R&D Expense | $13.4M | -3.4% | -41.6% |
| SG&A Expense | $11.0M | +38.0% | -38.0% |
| Operating Income | -$14.6M | -126.8% | +9.0% |
| Interest Expense | $8.1M | +3.1% | +15.9% |
| Pre-tax Income | $9.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $106.7M | -34.1% | -24.9% |
| Accounts Receivable | $19.2M | -18.1% | -61.5% |
| Current Assets | $143.7M | -37.7% | -32.6% |
| Total Assets | $511.4M | -15.4% | -26.1% |
| Current Liabilities | $122.2M | -13.1% | -27.5% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$20.8M | — | — |
| Capital Expenditures | $9.8M | — | — |
| Investing Cash Flow | -$11.2M | — | — |
| Financing Cash Flow | -$45.9M | — | — |
| Free Cash Flow | -$30.6M | — | — |
| +159.4% |
| +132.8% |
| Income Tax | $394K | +2.6% | -22.6% |
| Net Income | $8.7M | +155.4% | +130.8% |
| EPS (Basic) | $0.98 | +676.5% | +406.3% |
| EPS (Diluted) | -$2.76 | -1523.5% | -762.5% |
| $512.8M |
| -25.3% |
| -20.6% |
| Stockholders' Equity | -$22.1M | +73.2% | -148.0% |